25.03.2013 Views

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Nevertheless, both studies were of sufficient clinical and epidemiological similarity to<br />

attempt statistical pooling. Unfortunately, neither study examined the same outcomes in<br />

the same way, and individual data points are not given with which to manipulate<br />

statistically the effect measures for transformation on a common scale. Therefore, the<br />

review did not attempt a pooled estimate of treatment effect. Instead a brief description<br />

of results of the two studies follows.<br />

Review of published clinical experience<br />

Nighoghossian et al79 assessed functional outcome at six and 12 months using three<br />

scales: the Orgogozo, 81 Rankin disability, 82 and Trouillas scales. The latter was developed<br />

specifically for this study. The Orgogozo scale was a 100-point quantitative scale with a<br />

score of 100 as normal. It was the only scale used to measure baseline values. In the<br />

Rankin and Trouillas scales, a score of zero was considered normal.<br />

The authors found statistically significant differences between the intervention and<br />

comparison groups at 1 year based on the Orgogozo and Trouillas scores (Table 45).<br />

However, pre- and post-therapeutic differences were not statistically apparent on all<br />

scales.<br />

Table 45 Functional neurologic scores in intervention and comparison groups with cerebrovascular<br />

disease according to follow-up (Nighoghossian et al). 79<br />

Mean Score Treatment Difference<br />

Scale and Time of<br />

Examination Intervention Group Comparison<br />

Group<br />

Orgogozo<br />

Baseline<br />

6 months<br />

12 months<br />

Trouillas<br />

6 months<br />

12 months<br />

Rankin<br />

6 months<br />

12 months<br />

42.5 (5.1) †<br />

72.9 (6.6)<br />

78.2 (6.4)<br />

4.6 (0.5)<br />

4.1 (0.6)<br />

2.6 (0.2)<br />

2.4 (0.2)<br />

* Baseline comparisons were made for the Orgogozo scale only.<br />

† Figures in parentheses are standard errors.<br />

31.5 (5.3)<br />

54.7 (5.3)<br />

50.3 (8.7)<br />

6.1 (0.7<br />

6.3 (0.7)<br />

3.2 (0.3)<br />

3.0 (0.3)<br />

Intervention less<br />

Comparison<br />

11.0 (7.4)<br />

18.2 (10.6)<br />

27.9 (10.8)<br />

–1.5 (0.9)<br />

–2.2 (1.0)<br />

–0.6 (0.4)<br />

–0.6 (0.4)<br />

Anderson et al 80 used a graded neurological examination scale that was sensitive to<br />

deficits referable to the region of the brain perfused by branches of the internal carotid<br />

artery. 83 A score of 100 was considered normal. Examinations were administered on<br />

enrolment, at five days, six weeks, four months (the primary outcome of interest), and<br />

one year.<br />

The authors report that comparison therapy patients improved by (Mean ± SEM) 15.9 ±<br />

3.2 points (p < 0.0003) while the intervention group experiences an improvement in<br />

scores by 12.2 ± 4.8 points (p < 0.03). Due to the trend of better improvement in the<br />

comparison group compared to the HBO-exposed group, the study was suspended for<br />

ethical reasons.<br />

48 <strong>Hyperbaric</strong> oxygen therapy<br />

p<br />

0.15<br />

0.10<br />

0.02<br />

0.19<br />

0.03<br />

0.13<br />

0.11

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!